Showing results (21-30 of 264) with videos related to
Sort By:
Pageof 27
Psychoneuroendocrinology|June 29, 2004
Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic systemMarc A T Teunis, Cobi J Heijnen, Alexander R Cools, et al.Pain Reports|May 13, 2021
Autoimmune regulation of chronic painMichael J Lacagnina, Cobi J Heijnen, Linda R Watkins, et al.Neurobiology of Pain (Cambridge, Mass.)|June 9, 2020
CD3+ T cells are critical for the resolution of comorbid inflammatory pain and depression-like behaviorGeoffroy Laumet, Jules D Edralin, Robert Dantzer, et al.Brain, Behavior, and Immunity|December 16, 2021
An HDAC6 inhibitor reverses chemotherapy-induced mechanical hypersensitivity via an IL-10 and macrophage dependent pathwayJixiang Zhang, Jiacheng Ma, Ronnie T Trinh, et al.Journal of Neuroimmunology|March 8, 2005
Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter geneAnnemieke Kavelaars, Pieter M Cobelens, Marc A T Teunis, et al.Brain, Behavior, and Immunity|November 9, 2022
Chronic restraint stress impairs voluntary wheel running but has no effect on food-motivated behavior in miceKiersten Scott, Thien Trong Phan, Nabila Boukelmoune, et al.Current Neuropharmacology|June 2, 2011
Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injuryXiyong Fan, Annemieke Kavelaars, Cobi J Heijnen, et al.Pain|February 6, 2019
Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in miceGeoffroy Laumet, Jules D Edralin, Robert Dantzer, et al.Pain|October 17, 2015
Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μKaren Krukowski, Cora H Nijboer, XiaoJiao Huo, et al.Acta Neuropathologica Communications|October 2, 2018
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatmentJiacheng Ma, XiaoJiao Huo, Matthew B Jarpe, et al.Pageof 27